Deregulating Covid-19 Treatment Sets Dangerous Precedent for Vaccine Approval The FDA expedited the approval of convalescent plasma against the advice of its internal experts and those at the National Institute of Health. Were the federal government to continue this theme, one could expect the approval of an underregulated Covid-19 vaccine in the coming months.